0001193125-19-090821.txt : 20190329 0001193125-19-090821.hdr.sgml : 20190329 20190328191602 ACCESSION NUMBER: 0001193125-19-090821 CONFORMED SUBMISSION TYPE: N-Q PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20190131 FILED AS OF DATE: 20190329 DATE AS OF CHANGE: 20190328 EFFECTIVENESS DATE: 20190329 FILER: COMPANY DATA: COMPANY CONFORMED NAME: OPPENHEIMER SERIES FUND CENTRAL INDEX KEY: 0000356865 IRS NUMBER: 061207374 STATE OF INCORPORATION: DE FISCAL YEAR END: 1031 FILING VALUES: FORM TYPE: N-Q SEC ACT: 1940 Act SEC FILE NUMBER: 811-03346 FILM NUMBER: 19713452 BUSINESS ADDRESS: STREET 1: 6803 SOUTH TUCSON WAY STREET 2: N/A CITY: CENTENNIAL STATE: CO ZIP: 80112-3924 BUSINESS PHONE: 303-768-3200 MAIL ADDRESS: STREET 1: 6803 SOUTH TUCSON WAY STREET 2: N/A CITY: CENTENNIAL STATE: CO ZIP: 80112-3924 FORMER COMPANY: FORMER CONFORMED NAME: OPPENHEIMER SERIES FUND INC DATE OF NAME CHANGE: 19960909 FORMER COMPANY: FORMER CONFORMED NAME: CONNECTICUT MUTUAL INVESTMENT ACCOUNTS INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: CONNECTICUT MUTUAL LIQUID ACCOUNT INC DATE OF NAME CHANGE: 19851106 0000356865 S000007309 Oppenheimer Value Fund C000020080 A C000020082 C C000020083 R C000033091 Y C000110989 I N-Q 1 d666406dnq.htm OPPENHEIMER VALUE FUND Oppenheimer Value Fund

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM N-Q

QUARTERLY SCHEDULE OF PORTFOLIO HOLDINGS OF REGISTERED

MANAGEMENT INVESTMENT COMPANY

Investment Company Act file number 811-3346

Oppenheimer Series Fund

(Exact name of registrant as specified in charter)

6803 South Tucson Way, Centennial, Colorado 80112-3924

(Address of principal executive offices) (Zip code)

Cynthia Lo Bessette

OFI Global Asset Management, Inc.

225 Liberty Street, New York, New York 10281-1008

(Name and address of agent for service)

Registrant’s telephone number, including area code: (303) 768-3200

Date of fiscal year end: October 31

Date of reporting period: 1/31/2019


Item 1. Schedule of Investments.


STATEMENT OF INVESTMENTS January 31, 2019 Unaudited

 

     Shares     Value
Common Stocks—95.5%                
Consumer Discretionary—8.9%

 

       
Auto Components—1.1%    
BorgWarner, Inc.     441,350       $       18,051,215  
                 
Automobiles—1.9%    
General Motors Co.     774,810       30,233,086  
                 
Entertainment—1.5%    
Walt Disney Co. (The)     209,662       23,381,506  
                 
Hotels, Restaurants & Leisure—0.9%

 

 
McDonald’s Corp.     84,500       15,106,910  
                 
Household Durables—0.4%

 

 
Lennar Corp., Cl. A     119,880       5,684,710  
                 
Media—0.7%    
CBS Corp., Cl. B     220,120       10,887,135  
                 
Multiline Retail—1.8%    
Dollar Tree, Inc.1     42,040       4,070,733  
Target Corp.     352,600       25,739,800  
      29,810,533  
                 
Specialty Retail—0.6%    
Lowe’s Cos., Inc.     105,340       10,129,495  
                 
Consumer Staples—7.9%                
Beverages—3.5%    
Coca-Cola Co. (The)     709,020       34,125,133  
Coca-Cola European Partners plc     481,590       22,914,052  
      57,039,185  
                 
Food & Staples Retailing—1.9%

 

 
Walmart, Inc.     318,010       30,474,898  
                 
Food Products—0.2%    
General Mills, Inc.     74,990       3,332,556  
                 
Household Products—0.8%    
Procter & Gamble Co. (The)     131,650       12,700,275  
                 
Tobacco—1.5%    
Philip Morris International, Inc.     320,100       24,558,072  
                 
Energy—12.2%                
Energy Equipment & Services—0.5%

 

 
Transocean Ltd.1     339,450       2,909,086  
Weatherford International plc1     6,595,160       4,276,302  
      7,185,388  
     Shares     Value  
Oil, Gas & Consumable Fuels—11.7%

 

 
Anadarko Petroleum Corp.     357,670       $       16,928,521  
Chevron Corp.     424,326       48,648,976  
Concho Resources, Inc.1     110,600       13,254,304  
ConocoPhillips     314,748       21,305,292  
Enbridge, Inc.     443,697       16,248,184  
Marathon Petroleum Corp.     123,000       8,149,980  
Phillips 66     148,302       14,149,494  
Suncor Energy, Inc.     1,562,230       50,491,274  
      189,176,025  
                 
Financials—23.3%                
Capital Markets—3.8%    
Ameriprise Financial, Inc.     66,070       8,364,462  
BlackRock, Inc., Cl. A     59,250       24,593,490  
Charles Schwab Corp. (The)     216,440       10,122,899  
Goldman Sachs Group, Inc. (The)     85,110       16,852,631  
Nasdaq, Inc.     20,150       1,774,006  
      61,707,488  
                 
Commercial Banks—11.7%    
Bank of America Corp.     2,211,000       62,947,170  
CIT Group, Inc.     255,080       11,782,145  
Citigroup, Inc.     672,410       43,343,548  
JPMorgan Chase & Co.     253,950       26,283,825  
KeyCorp     815,980       13,439,191  
Zions Bancorp NA     645,490       30,718,869  
      188,514,748  
                 
Insurance—2.4%    
Aon plc     97,890       15,293,355  
Hartford Financial Services Group, Inc. (The)     513,800       24,107,496  
      39,400,851  
                 
Real Estate Investment Trusts (REITs)—5.4%

 

 
Crown Castle International Corp.     164,980       19,312,559  
Digital Realty Trust, Inc.     106,560       11,544,710  
Equity Residential     356,540       25,870,542  
Prologis, Inc.     346,586       23,969,888  
 

 

1        OPPENHEIMER VALUE FUND


STATEMENT OF INVESTMENTS Unaudited / Continued

 

     Shares     Value  
Real Estate Investment Trusts (REITs) (Continued)

 

Public Storage     30,530       $         6,488,236  
      87,185,935  
                 
Health Care—18.5%                
Biotechnology—0.8%    
Gilead Sciences, Inc.     184,250       12,899,342  
                 
Health Care Equipment & Supplies—5.5%

 

 
Abbott Laboratories     412,390       30,096,222  
Boston Scientific Corp.1     562,330       21,452,890  
Danaher Corp.     224,994       24,956,334  
Zimmer Biomet Holdings, Inc.     120,210       13,170,208  
      89,675,654  
                 
Health Care Providers & Services—5.2%    
Anthem, Inc.     79,610       24,121,830  
UnitedHealth Group, Inc.     222,271       60,057,624  
      84,179,454  
                 
Life Sciences Tools & Services—1.1%    
Thermo Fisher Scientific, Inc.     69,740       17,133,026  
                 
Pharmaceuticals—5.9%    
Merck & Co., Inc.     549,700       40,914,171  
Mylan NV1     217,610       6,517,420  
Pfizer, Inc.     1,133,890       48,133,630  
      95,565,221  
                 
Industrials—7.1%                
Aerospace & Defense—0.9%    
Lockheed Martin Corp.     48,230       13,971,748  
                 
Commercial Services & Supplies—1.2%    
Waste Management, Inc.     196,100       18,760,887  
                 
Construction & Engineering—0.4%    
Fluor Corp.     199,060       7,279,624  
                 
Machinery—3.1%    
Caterpillar, Inc.     142,260       18,943,342  
Deere & Co.     67,190       11,019,160  
Parker-Hannifin Corp.     119,715       19,730,229  
      49,692,731  
                 
Road & Rail—1.5%    
Kansas City Southern     161,710       17,100,833  
     Shares     Value  
Road & Rail (Continued)                
Union Pacific Corp.     45,190       $         7,188,373  
      24,289,206  
                 
Information Technology—9.2%                
Communications Equipment—2.9%    
Cisco Systems, Inc.     996,830       47,140,091  
                 
Electronic Equipment, Instruments, & Components—1.1%

 

TE Connectivity Ltd.     146,137       11,829,790  
Zebra Technologies Corp., Cl. A1     37,870       6,574,232  
      18,404,022  
                 
IT Services—1.0%    
Fidelity National Information Services, Inc.     79,390       8,298,637  
Mastercard, Inc., Cl. A     41,080       8,673,220  
      16,971,857  
                 
Semiconductors & Semiconductor Equipment—0.9%

 

Marvell Technology Group Ltd.     310,670       5,756,715  
Texas Instruments, Inc.     79,750       8,029,230  
      13,785,945  
                 
Software—2.7%    
Microsoft Corp.     249,330       26,037,532  
Synopsys, Inc.1     179,470       16,753,525  
      42,791,057  
                 
Technology Hardware, Storage & Peripherals—0.6%

 

HP, Inc.     413,510       9,109,625  
                 
Materials—2.7%                
Chemicals—1.0%    
Eastman Chemical Co.     202,195       16,300,961  
                 
Containers & Packaging—0.7%    
Westrock Co.     263,070       10,709,580  
                 
Metals & Mining—1.0%    
Alcoa Corp.1     283,590       8,416,951  
Freeport-McMoRan, Inc.     678,830       7,901,581  
      16,318,532  
 

 

2        OPPENHEIMER VALUE FUND


    

 

     Shares     Value  
Telecommunication Services—2.5%                
Diversified Telecommunication Services—2.5%

 

AT&T, Inc.     1,321,910       $       39,736,615  
                 
Utilities—3.2%                
Electric Utilities—3.2%    
Edison International     141,770       8,076,637  
Entergy Corp.     229,170       20,439,672  
NextEra Energy, Inc.     132,223       23,665,273  
      52,181,582  

Total Common Stocks

(Cost $1,292,925,416)

      1,541,456,771  
     Shares     Value  
Investment Company—4.7%                
Oppenheimer Institutional Government Money Market Fund, Cl. E, 2.35%2,3 (Cost $75,496,236)     75,496,236       $       75,496,236  
                 
Total Investments, at Value (Cost $1,368,421,652)     100.2%       1,616,953,007  
Net Other Assets (Liabilities)     (0.2)       (3,703,192)  

Net Assets

    100.0%       $  1,613,249,815  
               
 

Footnotes to Statement of Investments

1. Non-income producing security.

2. Rate shown is the 7-day yield at period end.

3. Is or was an affiliate, as defined in the Investment Company Act of 1940, as amended, at or during the reporting period, by virtue of the Fund owning at least 5% of the voting securities of the issuer or as a result of the Fund and the issuer having the same investment adviser. Transactions during the reporting period in which the issuer was an affiliate are as follows:

 

    

Shares

                October 31, 2018

   

Gross

                    Additions

   

Gross

                    Reductions

    Shares
                January 31, 2019
 
Investment Company        
Oppenheimer Institutional Government Money Market Fund, Cl. E     46,811,805       143,991,222       115,306,791       75,496,236  
     Value     Income    

Realized

Gain (Loss)

   

Change in

Unrealized

Gain (Loss)

 
Investment Company        
Oppenheimer Institutional Government Money Market Fund, Cl. E   $ 75,496,236     $ 207,588     $     $  

 

3        OPPENHEIMER VALUE FUND


NOTES TO STATEMENT OF INVESTMENTS January 31, 2019 Unaudited

 

 

1. Organization

Oppenheimer Value Fund (the “Fund”), a series of Oppenheimer Series Fund, is registered under the Investment Company Act of 1940 (“1940 Act”), as amended, as a diversified open-end management investment company. The Fund’s investment objective is to seek capital appreciation. The Fund’s investment adviser is OFI Global Asset Management, Inc. (“OFI Global” or the “Manager”), a wholly-owned subsidiary of OppenheimerFunds, Inc. (“OFI” or the “Sub-Adviser”). The Manager has entered into a sub-advisory agreement with OFI.

 

 

2. Securities Valuation

The Fund calculates the net asset value of its shares as of 4:00 P.M. Eastern Time, on each day the New York Stock Exchange (the “Exchange” or “NYSE”) is open for trading, except in the case of a scheduled early closing of the Exchange, in which case the Fund will calculate net asset value of the shares as of the scheduled early closing time of the Exchange.

    The Fund’s Board has adopted procedures for the valuation of the Fund’s securities and has delegated the day-to-day responsibility for valuation determinations under those procedures to the Manager. The Manager has established a Valuation Committee which is responsible for determining a fair valuation for any security for which market quotations are not readily available. The Valuation Committee’s fair valuation determinations are subject to review, approval and ratification by the Fund’s Board at least quarterly or more frequently, if necessary.

Valuation Methods and Inputs

Securities are valued primarily using unadjusted quoted market prices, when available, as supplied by third party pricing services or broker-dealers.

    The following methodologies are used to determine the market value or the fair value of the types of securities described below:

    Equity securities traded on a securities exchange (including exchange-traded derivatives other than futures and futures options) are valued based on the official closing price on the principal exchange on which the security is traded, as identified by the Manager, prior to the time when the Fund’s assets are valued. If the official closing price is unavailable, the security is valued at the last sale price on the principal exchange on which it is traded, or if no sales occurred, the security is valued at the mean between the quoted bid and asked prices. Over-the-counter equity securities are valued at the last published sale price, or if no sales occurred, at the mean between the quoted bid and asked prices. Events occurring after the close of trading on foreign exchanges may result in adjustments to the valuation of foreign securities to more accurately reflect their fair value as of the time when the Fund’s assets are valued.

    Shares of a registered investment company that are not traded on an exchange are valued at that investment company’s net asset value per share.

    Securities for which market quotations are not readily available, or when a significant event has occurred that would materially affect the value of the security, are fair valued either (i) by a standardized fair valuation methodology applicable to the security type or the significant event as previously approved by the Valuation Committee and the Fund’s Board or (ii) as determined in good faith by the Manager’s Valuation Committee. The Valuation Committee

 

4        OPPENHEIMER VALUE FUND


    

 

 

2. Securities Valuation (Continued)

considers all relevant facts that are reasonably available, through either public information or information available to the Manager, when determining the fair value of a security. Those standardized fair valuation methodologies include, but are not limited to, valuing securities at the last sale price or initially at cost and subsequently adjusting the value based on: changes in company specific fundamentals, changes in an appropriate securities index, or changes in the value of similar securities which may be further adjusted for any discounts related to security-specific resale restrictions. When possible, such methodologies use observable market inputs such as unadjusted quoted prices of similar securities, observable interest rates, currency rates and yield curves. The methodologies used for valuing securities are not necessarily an indication of the risks associated with investing in those securities nor can it be assured that the Fund can obtain the fair value assigned to a security if it were to sell the security.

Classifications

Each investment asset or liability of the Fund is assigned a level at measurement date based on the significance and source of the inputs to its valuation. Various data inputs may be used in determining the value of each of the Fund’s investments as of the reporting period end. These data inputs are categorized in the following hierarchy under applicable financial accounting standards:

1) Level 1-unadjusted quoted prices in active markets for identical assets or liabilities (including securities actively traded on a securities exchange)

2) Level 2-inputs other than unadjusted quoted prices that are observable for the asset or liability (such as unadjusted quoted prices for similar assets and market corroborated inputs such as interest rates, prepayment speeds, credit risks, etc.)

3) Level 3-significant unobservable inputs (including the Manager’s own judgments about assumptions that market participants would use in pricing the asset or liability).

The inputs used for valuing securities are not necessarily an indication of the risks associated with investing in those securities.

    The Fund classifies each of its investments in investment companies which are publicly offered as Level 1. Investment companies that are not publicly offered, if any, are classified as Level 2 in the fair value hierarchy.

The table below categorizes amounts at period end based on valuation input level:

 

    

Level 1—

Unadjusted

Quoted Prices

   

Level 2—

Other Significant
Observable Inputs

   

Level 3—

Significant

Unobservable

Inputs

    Value  
Assets Table        
Investments, at Value:        
Common Stocks        

Consumer Discretionary

  $         143,284,590     $                     —     $                     —     $             143,284,590   

Consumer Staples

    128,104,986                   128,104,986   

Energy

    196,361,413                   196,361,413   

 

5        OPPENHEIMER VALUE FUND


NOTES TO STATEMENT OF INVESTMENTS Unaudited / Continued

 

 

2. Securities Valuation (Continued)

 

    

Level 1—

Unadjusted

Quoted Prices

    

Level 2—

Other Significant

Observable Inputs

    

Level 3—

Significant

Unobservable

Inputs

    

Value

 
Common Stocks (Continued)           

Financials

  $ 376,809,022      $      $      $ 376,809,022    

Health Care

    299,452,697                      299,452,697    

Industrials

    113,994,196                      113,994,196    

Information Technology

    148,202,597                      148,202,597    

Materials

    43,329,073                      43,329,073    

Telecommunication Services

    39,736,615                      39,736,615    

Utilities

    52,181,582                      52,181,582    
Investment Company     75,496,236                      75,496,236    
                                  
Total Assets   $   1,616,953,007      $      $      $ 1,616,953,007    
                                  

    Forward currency exchange contracts and futures contracts, if any, are reported at their unrealized appreciation/depreciation at measurement date, which represents the change in the contract’s value from trade date. All additional assets and liabilities included in the above table are reported at their market value at measurement date.

    For the reporting period, there were no transfers between levels.

 

 

3. Investments and Risks

Investments in Affiliated Funds. The Fund is permitted to invest in other mutual funds advised by the Manager (“Affiliated Funds”). Affiliated Funds are management investment companies registered under the 1940 Act, as amended. The Manager is the investment adviser of, and the Sub-Adviser provides investment and related advisory services to, the Affiliated Funds. When applicable, the Fund’s investments in Affiliated Funds are included in the Statement of Investments. Shares of Affiliated Funds are valued at their net asset value per share. As a shareholder, the Fund is subject to its proportional share of the Affiliated Funds’ expenses, including their management fee. The Manager will waive fees and/or reimburse Fund expenses in an amount equal to the indirect management fees incurred through the Fund’s investment in the Affiliated Funds.

    Each of the Affiliated Funds in which the Fund invests has its own investment risks, and those risks can affect the value of the Fund’s investments and therefore the value of the Fund’s shares. To the extent that the Fund invests more of its assets in one Affiliated Fund than in another, the Fund will have greater exposure to the risks of that Affiliated Fund.

Investments in Money Market Instruments. The Fund is permitted to invest its free cash balances in money market instruments to provide liquidity or for defensive purposes. The Fund may invest in money market instruments by investing in Class E shares of Oppenheimer Institutional Government Money Market Fund (“IGMMF”), which is an Affiliated Fund. IGMMF is regulated as a money market fund under the 1940 Act, as amended. The Fund may also invest in money market instruments directly or in other affiliated or unaffiliated money market funds.

 

6        OPPENHEIMER VALUE FUND


    

 

 

3. Investments and Risks (Continued)

Equity Security Risk. Stocks and other equity securities fluctuate in price. The value of the Fund’s portfolio may be affected by changes in the equity markets generally. Equity markets may experience significant short-term volatility and may fall sharply at times. Different markets may behave differently from each other and U.S. equity markets may move in the opposite direction from one or more foreign stock markets. Adverse events in any part of the equity or fixed-income markets may have unexpected negative effects on other market segments.

    The prices of individual equity securities generally do not all move in the same direction at the same time and a variety of factors can affect the price of a particular company’s securities. These factors may include, but are not limited to, poor earnings reports, a loss of customers, litigation against the company, general unfavorable performance of the company’s sector or industry, or changes in government regulations affecting the company or its industry.

 

 

4. Market Risk Factors

The Fund’s investments in securities and/or financial derivatives may expose the Fund to various market risk factors:

Commodity Risk. Commodity risk relates to the change in value of commodities or commodity indexes as they relate to increases or decreases in the commodities market. Commodities are physical assets that have tangible properties. Examples of these types of assets are crude oil, heating oil, metals, livestock, and agricultural products.

Credit Risk. Credit risk relates to the ability of the issuer of debt to meet interest and principal payments, or both, as they come due. In general, lower-grade, higher-yield debt securities are subject to credit risk to a greater extent than lower-yield, higher-quality securities.

Equity Risk. Equity risk relates to the change in value of equity securities as they relate to increases or decreases in the general market.

Foreign Exchange Rate Risk. Foreign exchange rate risk relates to the change in the U.S. dollar value of a security held that is denominated in a foreign currency. The U.S. dollar value of a foreign currency denominated security will decrease as the dollar appreciates against the currency, while the U.S. dollar value will increase as the dollar depreciates against the currency.

Interest Rate Risk. Interest rate risk refers to the fluctuations in value of fixed-income securities resulting from the inverse relationship between price and yield. For example, an increase in general interest rates will tend to reduce the market value of already issued fixed-income investments, and a decline in general interest rates will tend to increase their value. In addition, debt securities with longer maturities, which tend to have higher yields, are subject to potentially greater fluctuations in value from changes in interest rates than obligations with shorter maturities.

Volatility Risk. Volatility risk refers to the magnitude of the movement, but not the direction of the movement, in a financial instrument’s price over a defined time period. Large increases or decreases in a financial instrument’s price over a relative time period typically indicate greater volatility risk, while small increases or decreases in its price

 

7        OPPENHEIMER VALUE FUND


NOTES TO STATEMENT OF INVESTMENTS Unaudited / Continued

 

 

4. Market Risk Factors (Continued)

typically indicate lower volatility risk.

 

 

5. Pending Acquisition

On October 18, 2018, Massachusetts Mutual Life Insurance Company, an indirect corporate parent of the Sub-Adviser and the Manager, announced that it has entered into an agreement whereby Invesco Ltd. (“Invesco”), a global investment management company, will acquire the Sub-Adviser (the “Transaction”). In connection with the Transaction, on January 11, 2019, the Fund’s Board unanimously approved an Agreement and Plan of Reorganization (the “Agreement”), which provides for the transfer of the assets and liabilities of the Fund to a corresponding, newly formed fund (the “Acquiring Fund”) in the Invesco family of funds (the “Reorganization”) in exchange for shares of the corresponding Acquiring Fund of equal value to the value of the shares of the Fund as of the close of business on the closing date. Although the Acquiring Fund will be managed by Invesco Advisers, Inc., the Acquiring Fund will, as of the closing date, have the same investment objective and substantially similar principal investment strategies and risks as the Fund. After the Reorganization, Invesco Advisers, Inc. will be the investment adviser to the Acquiring Fund, and the Fund will be liquidated and dissolved under applicable law and terminate its registration under the Investment Company Act of 1940, as amended. The Reorganization is expected to be a tax-free reorganization for U.S. federal income tax purposes.

    The Reorganization is subject to the approval of shareholders of the Fund. Shareholders of record of the Fund on January 14, 2019 will be entitled to vote on the Reorganization and will receive a combined prospectus and proxy statement describing the Reorganization, the shareholder meeting, and a discussion of the factors the Fund’s Board considered in approving the Agreement. The combined prospectus and proxy statement is expected to be distributed to shareholders of record on or about February 28, 2019. The anticipated date of the shareholder meeting is on or about April 12, 2019.

    If shareholders approve the Agreement and certain other closing conditions are satisfied or waived, the Reorganization is expected to close during the second quarter of 2019, or as soon as practicable thereafter. This is subject to change.

 

8        OPPENHEIMER VALUE FUND


Item 2. Controls and Procedures.

 

  (a)

Based on their evaluation of the registrant’s disclosure controls and procedures (as defined in rule 30a-3(c) under the Investment Company Act of 1940 (17 CFR 270.30a-3(c)) as of 1/31/2019, the registrant’s principal executive officer and principal financial officer found the registrant’s disclosure controls and procedures to provide reasonable assurances that information required to be disclosed by the registrant in the reports that it files under the Securities Exchange Act of 1934 (a) is accumulated and communicated to the registrant’s management, including its principal executive officer and principal financial officer, to allow timely decisions regarding required disclosure, and (b) is recorded, processed, summarized and reported, within the time periods specified in the rules and forms adopted by the U.S. Securities and Exchange Commission.


  (b)

There have been no significant changes in the registrant’s internal controls over financial reporting that occurred during the registrant’s last fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting.

Item 3. Exhibits.

Exhibits attached hereto.


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Oppenheimer Series Fund

 

By:  

/s/ Arthur P. Steinmetz

    Arthur P. Steinmetz
    Principal Executive Officer
Date:   3/15/2019

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

 

By:  

/s/ Arthur P. Steinmetz

 

  Arthur P. Steinmetz
    Principal Executive Officer
Date:   3/15/2019

 

By:  

/s/ Brian S. Petersen

  Brian S. Petersen
  Principal Financial Officer
Date:   3/15/2019
EX-99.CERT 2 d666406dex99cert.htm SECTION 302 CERTIFICATIONS Section 302 Certifications

Exhibit 99.CERT

Section 302 Certifications

CERTIFICATIONS

I, Arthur P. Steinmetz, certify that:

 

1.

I have reviewed this report on Form N-Q of Oppenheimer Series Fund;

 

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.

Based on my knowledge, the schedules of investments included in this report fairly present in all material respects the investments of the registrant as of the end of the fiscal quarter for which the report is filed;

 

4.

The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940) and internal control over financial reporting (as defined in Rule 30a-3(d) under the Investment Company Act of 1940) for the registrant and have:

 

  (a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

  (b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

  (c)

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of a date within 90 days prior to the filing date of this report, based on such evaluation; and

 

  (d)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and


5.

The registrant’s other certifying officer and I have disclosed to the registrant’s auditors and the audit committee of the registrant’s board of Trustees (or persons performing the equivalent functions):

 

  (a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize, and report financial information; and

 

  (b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

/s/ Arthur P. Steinmetz

Arthur P. Steinmetz
Principal Executive Officer
Date: 3/15/2019


Exhibit 99.CERT

Section 302 Certifications

CERTIFICATIONS

I, Brian S. Petersen, certify that:

 

1.

I have reviewed this report on Form N-Q of Oppenheimer Series Fund;

 

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.

Based on my knowledge, the schedules of investments included in this report fairly present in all material respects the investments of the registrant as of the end of the fiscal quarter for which the report is filed;

 

4.

The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940) and internal control over financial reporting (as defined in Rule 30a-3(d) under the Investment Company Act of 1940) for the registrant and have:

 

  (a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

  (b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

  (c)

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of a date within 90 days prior to the filing date of this report, based on such evaluation; and

 

  (d)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and


5.

The registrant’s other certifying officer and I have disclosed to the registrant’s auditors and the audit committee of the registrant’s board of Trustees (or persons performing the equivalent functions):

 

  (a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize, and report financial information; and

 

  (b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

/s/ Brian S. Petersen

Brian S. Petersen
Principal Financial Officer
Date: 3/15/2019